|  |  |  | E6 nucleotide position |  | E7 nucleotide position | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  |  | Amino acid changes |  | R10G | R101/R10T | L12I | L12S | P13G |  | Q14D | Q14H | E29Q | C51F | A6IG |  |  | D64E | H78Y |  | D2IN | N29S |  |  |
 |  |  |  | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 6 | 6 | 7 | 7 |
 |  |  |  | 0 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 8 | 5 | 8 | 8 | 8 | 9 | 3 | 0 | 2 | 4 | 8 | 9 |
 |  |  |  | 9 | 1 | 2 | 7 | 8 | 1 | 2 | 3 | 5 | 8 | 5 | 5 | 6 | 9 | 5 | 5 | 3 | 2 | 7 | 9 | 5 |
 |  |  | HPV16 Ref (NC_001526) | T | A | G | T | T | C | A | C | G | G | G | C | T | A | T | C | A | G | A | T | T |
Variant Lineages | Variant Sub-lineages | Novel nomenclature | Prevalence | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
No. (%) | ||||||||||||||||||||||||
Af-1 | Af-la | B1 | 4 (30.7) | Â | Â | C | Â | Â | Â | Â | g | G | T | C | Â | a | g | Â | T | Â | Â | Â | c | g |
Af-Ib/G295 | B2 | 1 (7.7) | Â | Â | C | Â | Â | Â | Â | Â | G | T | Â | Â | a | g | G | T | Â | Â | Â | c | g | |
Af-Ib/G131 | B2 | 2 (15.4) | Â | G | C | Â | Â | Â | Â | Â | G | T | Â | Â | a | g | Â | T | Â | Â | Â | c | g | |
Af-2 | Af-2a/r | C/C1 | 3 (23.0) | c | Â | T | Â | Â | Â | Â | G | T | Â | Â | Â | a | g | Â | T | g | A* | Â | c | g |
Af-2a/C109/C138 | 1 (7.7) | c | Â | T | Â | C | Â | Â | G | T | Â | Â | Â | a | g | G | T | g | Â | G | c | g | ||
Af-2a/C109/A137 | 1 (7.7) | c | Â | T | A | Â | G | Â | G | T | Â | Â | Â | a | g | Â | T | g | Â | G | c | g | ||
Af-2a/C109/G285 | 1 (7.7) | c | Â | T | Â | Â | Â | Â | G | T | Â | Â | G | a | g | Â | T | g | Â | G | c | g | ||
 |  |  | Mutation prevalence (%) | 46.1 | 15.4 | 53.8/46.1 | 7.7 | 7.7 | 7.7 | 7.7 | 100 | 100 | 30.7 | 15.4 | 7.7 | 100 | 100 | 7.7 | 100 | 46.1 | 23.0 | 23.0 | 100 | 100 |